<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Amifampridine</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/3%2C4-Diaminopyridine">
  <link href="../-/s/css_modules/mediawiki.action.view.redirectPage.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.action.view.redirectPage.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Amifampridine</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Amifampridine</b> (<b>pyridine-3,4-diamine</b>, <b>3,4-diaminopyridine</b>, <b>3,4-DAP</b>) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using <i>ad hoc</i> forms of the drug, since there was no marketed form.</p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Amifampridine</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Diaminopyridine.png" tppabs="https://ptable.com/wiki/compounds/I/m/Diaminopyridine.png" data-file-width="895" data-file-height="856" data-file-type="bitmap" height="115" width="120"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/3,4-diaminopyridine-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/3%2C4-diaminopyridine-3D-balls.png" data-file-width="1100" data-file-height="1100" data-file-type="bitmap" height="120" width="120"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Firdapse, Ruzurgi</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/uk/firdapse.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/uk/firdapse.html'" tppabs="https://www.drugs.com/uk/firdapse.html" class="external text external">UK Drug Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Amifampridine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Amifampridine'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Amifampridine" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>No clinical data</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>N07XX05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=N07XX05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=N07XX05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=N07XX05" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>93–100%<span class="mw-ref" id="cite_ref-EMAlabel2010_1-0"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Acetylation to 3-<i>N</i>-acetyl<span>­</span>amifampridine</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>2.5 hrs (amifampridine)<br>4 hrs (3-<i>N</i>-acetyl<span>­</span>amifampridine)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Renal (19% unmetabolized, 74–81% 3-<i>N</i>-acetyl<span>­</span>amifampridine</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">Pyridine-3,4-diamine</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=54-96-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=54-96-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=54-96-6" class="external text external">54-96-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5918  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5918'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5918" class="external text external">5918</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8032'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8032" class="external text external">8032</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5705.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5705.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5705.html" class="external text external">5705</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RU4S6E2G0J  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RU4S6E2G0J'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=RU4S6E2G0J" class="external text external">RU4S6E2G0J</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D10228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D10228'" tppabs="https://www.kegg.jp/entry/D10228" class="external text external">D10228</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL354077  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL354077'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL354077" class="external text external">ChEMBL354077</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID6046715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID6046715'" tppabs="https://comptox.epa.gov/dashboard/DTXSID6046715" class="external text external">DTXSID6046715</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.201'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.201" class="external text external">100.000.201</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>5</sub><span>H</span><sub>7</sub><span>N</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">109.132</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=c1cncc%28c1N%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=c1cncc%28c1N%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=c1cncc%28c1N%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>218 to 220<span>&nbsp;</span>°C (424 to 428<span>&nbsp;</span>°F) decomposes</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Solubility in water</th><td>24<span>&nbsp;</span>mg/mL (20<span>&nbsp;</span>°C)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">c1cncc(c1N)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:OYTKINVCDFNREN-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477217342&page2=Amifampridine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477217342&page2=Amifampridine'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477217342&page2=Amifampridine" class="external text external">(verify)</a></span></span></td></tr></tbody></table>
<p>Around 2000 doctors at Assistance Publique – Hôpitaux de Paris created a phosphate salt form, which was developed through a series of companies ending with BioMarin Pharmaceutical which obtained European approval in 2009 under the trade name <b>Firdapse</b>, and which licensed the US rights to Catalyst Pharmaceuticals in 2012. As of January 2017, Catalyst and another US company, <span class="new">Jacobus Pharmaceutical</span>, which had been manufacturing and giving it away for free since the 1990s, were both seeking FDA approval for their iterations and marketing rights.</p>

<p>Amifampridine phosphate has orphan drug status in the EU for Lambert–Eaton myasthenic syndrome and Catalyst holds both an orphan designation and a breakthrough therapy designation in the US. In May 2019 the U.S. Food and Drug Administration (FDA) approved amifampridine tablets under the trade name <b>Ruzurgi</b> for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age. This is the first FDA approval of a treatment specifically for pediatric patients with LEMS. The FDA granted the approval of Ruzurgi to Jacobus Pharmaceutical. The only other treatment approved for LEMS (Firdapse) is only approved for use in adults.<span class="mw-ref" id="cite_ref-FDA__Ruzurgi_2-0"><a href="#cite_note-FDA__Ruzurgi-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Amifampridine is used to treat many of the congenital myasthenic syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and those where any kind of defect causes "fast channel" behaviour of the acetylcholine receptor.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span>
It is also used to treat psoriasis.
It is also used to treat symptoms of Lambert–Eaton myasthenic syndrome.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-1"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Cochrane2011_5-0"><a href="#cite_note-Cochrane2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Because it affects voltage-gated ion channels in the heart, it is contraindicated in people with long QT syndrome and in people taking a drug that might prolong QT time like <a href="Sultopride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sultopride" title="Sultopride">sultopride</a>, <a href="Disopyramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Disopyramide" title="Disopyramide">disopyramide</a>, <a href="Cisapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisapride" title="Cisapride">cisapride</a>, <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">rifampicin</a> or ketoconazol. It is also contraindicated in people with epilepsy or badly controlled asthma.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-2"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>The dose-limiting side effects include tingling or numbness, difficulty sleeping, fatigue, and loss of muscle strength.<span class="mw-ref" id="cite_ref-Tarr2015rev_6-0"><a href="#cite_note-Tarr2015rev-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Amifampridine can cause seizures, especially but not exclusively when given at high doses and/or in particularly vulnerable individuals who have a history of seizures.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-3"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>The combination of amifampridine with pharmaceuticals that prolong QT time increases the risk of ventricular tachycardia, especially torsade de pointes; and combination with drugs that lower the seizure threshold increases the risk of seizures. Interactions via the liver's cytochrome P450 enzyme system are considered unlikely.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-4"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>In Lambert–Eaton myasthenic syndrome, <a href="Acetylcholine.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetylcholine" title="Acetylcholine">acetylcholine</a> release is inhibited as antibodies involved in the host response against certain cancers cross-react with Ca<sup>2+</sup> channels on the prejunctional membrane. Amifampridine works by blocking potassium channel efflux in nerve terminals so that action potential duration is increased.<span class="mw-ref" id="cite_ref-kirsch_narahashi_1978_7-0"><a href="#cite_note-kirsch_narahashi_1978-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Ca<sup>2+</sup> channels can then be open for a longer time and allow greater acetylcholine release to stimulate muscle at the end plate.<span class="mw-ref" id="cite_ref-Tarr2015rev_6-1"><a href="#cite_note-Tarr2015rev-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Acetylamifampridine_skeletal.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Acetylamifampridine_skeletal.svg.png" data-file-width="230" data-file-height="193" data-file-type="drawing" height="185" width="220"><div class="thumbcaption" style="text-align: left"><i>N</i>-(4-Amino-3-pyridinyl)acetamide or 3-<i>N</i>-acetylamifampridine, the metabolite</div></div></div>
<p>Amifampridine is quickly and almost completely (93–100%) absorbed from the gut. In a study with 91 healthy subjects, maximum amifampridine concentrations in blood plasma were reached after 0.6 (±0.25) hours when taken without food, or after 1.3 (±0.9) hours after a fatty meal, meaning that the speed of absorption varies widely. Biological half-life (2.5±0.7<span>&nbsp;</span>hrs) and the area under the curve (AUC = 117±77<span>&nbsp;</span>ng∙h/ml) also vary widely between subjects, but are nearly independent of food intake.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-5"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>The substance is deactivated by acetylation via N-acetyltransferases to the single metabolite 3-<i>N</i>-acetylamifampridine. Activity of these enzymes (primarily N-acetyltransferase 2) in different individuals seems to be primarily responsible for the mentioned differences in half-life and AUC: the latter is increased up to 9-fold in slow metabolizers as compared to fast metabolizers.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-6"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>Amifampridine is eliminated via the kidneys and urine to 74–81% as <i>N</i>-acetylamifampridine and to 19% in unchanged form.<span class="mw-ref" id="cite_ref-EMAlabel2010_1-7"><a href="#cite_note-EMAlabel2010-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>3,4-Diaminopyridine is a pale yellow to pale brown crystalline powder that melts at about <span>218–220</span><span>&nbsp;</span><span>°C (424–428</span><span>&nbsp;</span><span>°F)</span> under decomposition. It is readily soluble in <a href="Methanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanol" title="Methanol">methanol</a>, <a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">ethanol</a> and hot water, but only slightly in <a href="Diethyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether" title="Diethyl ether">diethyl ether</a>.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Dinnendahl_9-0"><a href="#cite_note-Dinnendahl-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Solubility in water at <span>20</span><span>&nbsp;</span><span>°C (68</span><span>&nbsp;</span><span>°F)</span> is 25<span>&nbsp;</span>g/L.</p>

<p>The drug formulation amifampridine phosphate contains the phosphate salt, more specifically 4-aminopyridine-3-ylammonium dihydrogen phosphate.<span class="mw-ref" id="cite_ref-Dinnendahl_9-1"><a href="#cite_note-Dinnendahl-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> This salt forms prismatic, monoclinic crystals (space group C2/c)<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> and is readily soluble in water.<span class="mw-ref" id="cite_ref-Klement_11-0"><a href="#cite_note-Klement-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The phosphate salt is stable, and does not require refrigeration.<span class="mw-ref" id="cite_ref-NHS2015_12-0"><a href="#cite_note-NHS2015-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The development of amifampridine and its phosphate has brought attention to orphan drug policies that grant market exclusivity as an incentive for companies to develop therapies for conditions that affect small numbers of people.<span class="mw-ref" id="cite_ref-NYT2015_13-0"><a href="#cite_note-NYT2015-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Amifampridine, also called 3,4-DAP, was discovered in Scotland in the 1970s, and doctors in Sweden first showed its use in LEMS in the 1980s.<span class="mw-ref" id="cite_ref-BillHealth2016_16-0"><a href="#cite_note-BillHealth2016-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>In the 1990s, doctors in the US, on behalf of Muscular Dystrophy Association, approached a small family-owned manufacturer of active pharmaceutical ingredients in New Jersey, Jacobus Pharmaceuticals, about manufacturing amifampridine so they could test it in clinical trials. Jacobus did so, and when the treatment turned out to be effective, Jacobus and the doctors were faced with a choice — invest in clinical trials to get FDA approval or give the drug away for free under a compassionate use program to about 200 patients out of the estimated 1500-3000 LEMS patients in the U.S.. Jacobus elected to give the drug away to this subset of LEMS patients, and did so for about twenty years.<span class="mw-ref" id="cite_ref-Stat2016_17-0"><a href="#cite_note-Stat2016-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-DrugR&amp;D2015_18-0"><a href="#cite_note-DrugR&amp;D2015-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Doctors at the Assistance Publique – Hôpitaux de Paris had created a phosphate salt of 3,4-DAP (3,4-DAPP), and obtained an orphan designation for it in Europe in 2002.<span class="mw-ref" id="cite_ref-EMAorphan_20-0"><a href="#cite_note-EMAorphan-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> The hospital licensed the intellectual property on the phosphate form to the French biopharma company OPI, which was acquired by EUSA Pharma in 2007,<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> and the orphan application was transferred to EUSA in 2008.<span class="mw-ref" id="cite_ref-EMAorphan_20-1"><a href="#cite_note-EMAorphan-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> In 2008 EUSA submitted an application for approval to market the phosphate form to the European Medicines Agency under the brand name Zenas.<span class="mw-ref" id="cite_ref-ZenasEMA2009_22-0"><a href="#cite_note-ZenasEMA2009-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> EUSA, through a vehicle called Huxley Pharmaceuticals, sold the rights to 3,4-DAPP to BioMarin in 2009,<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> the same year that 3,4-DAPP was approved in Europe under the new name Firdapse.<span class="mw-ref" id="cite_ref-EMAorphan_20-2"><a href="#cite_note-EMAorphan-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>The licensing of Firdapse in 2010 in Europe led to a sharp increase in price for the drug. In some cases, this has led to hospitals using an unlicensed form rather than the licensed agent, as the price difference proved prohibitive. BioMarin has been criticized for licensing the drug on the basis of previously conducted research, and yet charging exorbitantly for it.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> A group of UK neurologists and pediatricians petitioned to prime minister David Cameron in an open letter to review the situation.<span class="mw-ref" id="cite_ref-Nichol_25-0"><a href="#cite_note-Nichol-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> The company responded that it submitted the licensing request at the suggestion of the French government, and points out that the increased cost of a licensed drug also means that it is monitored by regulatory authorities (e.g. for uncommon side effects), a process that was previously not present in Europe.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> A 2011 Cochrane review compared the cost of the 3,4-DAP and 3,4-DAPP in the UK and found an average price for 3,4-DAP base of £1/tablet and an average price for 3,4-DAP phosphate of £20/tablet; and the authors estimated a yearly cost per person of £730 for the base versus £29,448 for the phosphate formulation.<span class="mw-ref" id="cite_ref-Cochrane2011_5-1"><a href="#cite_note-Cochrane2011-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-NHS2015_12-1"><a href="#cite_note-NHS2015-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Meanwhile, in Europe, a task force of neurologists had recommended 3,4-DAP as the firstline treatment for LEMS symptoms in 2006, even though there was no approved form for marketing; it was being supplied <i>ad hoc</i>.<span class="mw-ref" id="cite_ref-ZenasEMA2009_22-1"><a href="#cite_note-ZenasEMA2009-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><sup class="reference" style="white-space:nowrap;">:<span>5</span></sup><span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> In 2007 the drug's international nonproprietary name was published by the WHO.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>

<p>In the face of the 7 year exclusivity that an orphan approval would give to Biomarin, and of the increase in price that would accompany it, Jacobus began racing to conduct formal clinical trials in order to get approval for the free base form before BioMarin; its first Phase II trial was opened in January 2012.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>In October 2012, while BioMarin had a Phase III trial ongoing in the US, it licensed the US rights to 3,4-DAPP, including the orphan designation and the ongoing trial, to Catalyst Pharmaceuticals.<span class="mw-ref" id="cite_ref-SFBJ2012_30-0"><a href="#cite_note-SFBJ2012-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Catalyst anticipated that it could earn $300 to $900 million per year in sales at peak sales for treatment of people with LEMS and other indications, and analysts anticipated the drug would be priced at around. $100,000 in the US.<span class="mw-ref" id="cite_ref-BillHealth2016_16-1"><a href="#cite_note-BillHealth2016-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Catalyst went on to obtain a breakthrough therapy designation for 3,4-DAPP in LEMS in 2013,<span class="mw-ref" id="cite_ref-:0_31-0"><a href="#cite_note-:0-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> an orphan designation for congenital myasthenic syndromes in 2015<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> and an orphan designation for myasthenia gravis in 2016.<span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>

<p>In August 2013, analysts anticipated that FDA approval would be granted to Catalyst in LEMS by 2015.<span class="mw-ref" id="cite_ref-:0_31-1"><a href="#cite_note-:0-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<p>In October 2014, Catalyst began making available under an expanded access program.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>

<p>In March 2015 Catalyst obtained an orphan designation for the use of 3,4-DAPP to treat of congenital myasthenic syndrome.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> In April 2015, Jacobus presented clinical trial results with 3,4-DAP at a scientific meeting.<span class="mw-ref" id="cite_ref-DrugR&amp;D2015_18-1"><a href="#cite_note-DrugR&amp;D2015-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>In December 2015 a group of 106 neuromuscular doctors who had worked with both Jacobus and BioMarin/Catalyst published an editorial in the journal, <i>Muscle &amp; Nerve</i>, expressing concern about the potential for the price of the drug to be dramatically increased should Catalyst obtain FDA approval, and stating that 3,4-DAPP represented no real innovation and didn't deserve exclusivity under the Orphan Drug Act, which was meant to spur innovation to meet unmet needs.<span class="mw-ref" id="cite_ref-BillHealth2016_16-2"><a href="#cite_note-BillHealth2016-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> Catalyst responded to this editorial with a response in 2016 that explained that Catalyst was conducting a full range of clinical and non-clinical studies necessary to obtain approval in order to specifically address the unmet need among the estimated 1500-3000 LEMs patients since about 200 were receiving the product through compassionate use – and that this is exactly what the Orphan Drug Act was intended to do: deliver approved products to orphan drug populations so that all patients have full access.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>

<p>In December 2015 Catalyst submitted its new drug application to the FDA,<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> and in February 2016 the FDA refused to accept it, on the basis that it wasn't complete and in April 2016 the FDA told Catalyst it would have to gather further data.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-NYT2015_13-1"><a href="#cite_note-NYT2015-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Catalyst cut 30% of its workforce, mainly from the commercial team it was building to support an approved product, to save money to conduct the trials.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> In March 2018 the company re-submitted its NDA.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> The FDA approved amifampridine for the treatment of adults with Lambert-Eaton myasthenic syndrome on November 29, 2018.<span class="mw-ref" id="cite_ref-42"><a href="#cite_note-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>

<p>In February 2019, U.S. Senator Bernie Sanders questioned the high price ($375,000) charged by Catalyst Pharmaceuticals for Firdapse.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<p>In May 2019 the privately held US company Jacobus Pharmaceutical, Princeton, New Jersey gained approval by the FDA for amifampridine tablets (<i>Ruzurgi</i>) for the treatment of LEMS in patients 6 to less than 17 years of age. This is the first FDA approval of a treatment specifically for pediatric patients with LEMS. <i>Firdapse</i> is only approved for use in adults.<span class="mw-ref" id="cite_ref-FDA__Ruzurgi_2-1"><a href="#cite_note-FDA__Ruzurgi-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Although <i>Ruzurgi</i> has been approved for pediatric patients, this approval makes it possible for adults with LEMS to get the drug off-label. Jacobus Pharmaceutical had been manufacturing and giving it away for free since the 1990s. The FDA decision dropped the stock of Catalyst Pharmaceuticals. The company's stock price has dropped about 50%.<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Amifampridine has also been proposed for the treatment of multiple sclerosis (MS). A 2002 Cochrane systematic review found that there was no unbiased data to support its use for treating MS.<span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> There was no change as of 2012.<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li><a href="4-Aminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Aminopyridine" title="4-Aminopyridine">4-Aminopyridine</a></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-EMAlabel2010-1"> <span id="mw-reference-text-cite_note-EMAlabel2010-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001032/WC500069915.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001032/WC500069915.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001032/WC500069915.pdf" class="external text external">"Firdapse Summary of Product Characteristics"</a> <span class="cs1-format">(PDF)</span>. EMA. February 11, 2010.</cite> See <a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001032/human_med_001298.jsp  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001032/human_med_001298.jsp'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001032/human_med_001298.jsp" class="external text external">EMA Index page, product tab</a></span></li><li id="cite_note-FDA__Ruzurgi-2"> <span id="mw-reference-text-cite_note-FDA__Ruzurgi-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder" class="external text external">"FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder"</a>. <i>fda.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-05-11</span></span>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFArgov2009" class="citation journal cs1">Argov Z (October 2009). "Management of myasthenic conditions: nonimmune issues". <i>Current Opinion in Neurology</i>. <b>22</b> (5): 493–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FWCO.0b013e32832f15fa  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FWCO.0b013e32832f15fa'" tppabs="https://doi.org/10.1097%2FWCO.0b013e32832f15fa" class="external text external">10.1097/WCO.0b013e32832f15fa</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19593127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19593127'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19593127" class="external text external">19593127</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFAbichtMüllerLochmüller2016" class="citation web cs1">Abicht, Angela; Müller, Juliane; Lochmüller, Hanns (July 14, 2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/books/NBK1168/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/books/NBK1168/'" tppabs="https://www.ncbi.nlm.nih.gov/books/NBK1168/" class="external text external">"Congenital Myasthenic Syndromes"</a>. <i>GeneReviews</i>. University of Washington, Seattle.</cite></span></li><li id="cite_note-Cochrane2011-5"> <span id="mw-reference-text-cite_note-Cochrane2011-5" class="mw-reference-text"><cite id="CITEREFKeoghSedehizadehMaddison2011" class="citation journal cs1">Keogh M, Sedehizadeh S, Maddison P (2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613" class="external text external">"Treatment for Lambert-Eaton myasthenic syndrome"</a>. <i>The Cochrane Database of Systematic Reviews</i> (2): CD003279. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003279.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003279.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD003279.pub3" class="external text external">10.1002/14651858.CD003279.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003613" class="external text external">7003613</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21328260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21328260'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21328260" class="external text external">21328260</a>.</cite></span></li><li id="cite_note-Tarr2015rev-6"> <span id="mw-reference-text-cite_note-Tarr2015rev-6" class="mw-reference-text"><cite id="CITEREFTarrWipfMeriney2015" class="citation journal cs1">Tarr, TB; Wipf, P; Meriney, SD (August 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862" class="external text external">"Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome"</a>. <i>Molecular Neurobiology</i>. <b>52</b> (1): 456–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs12035-014-8887-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs12035-014-8887-2'" tppabs="https://doi.org/10.1007%2Fs12035-014-8887-2" class="external text external">10.1007/s12035-014-8887-2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362862" class="external text external">4362862</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25195700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25195700'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25195700" class="external text external">25195700</a>.</cite></span></li><li id="cite_note-kirsch_narahashi_1978-7"> <span id="mw-reference-text-cite_note-kirsch_narahashi_1978-7" class="mw-reference-text"><cite id="CITEREFKirschNarahashi1978" class="citation journal cs1">Kirsch GE, Narahashi T (June 1978). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482" class="external text external">"3,4-diaminopyridine. A potent new potassium channel blocker"</a>. <i>Biophys J</i>. <b>22</b> (3): 507–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0006-3495%2878%2985503-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0006-3495%2878%2985503-9'" tppabs="https://doi.org/10.1016%2Fs0006-3495%2878%2985503-9" class="external text external">10.1016/s0006-3495(78)85503-9</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473482" class="external text external">1473482</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/667299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/667299'" tppabs="https://pubmed.ncbi.nlm.nih.gov/667299" class="external text external">667299</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/ohrms/dockets/dockets/98n0182/nom007b.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/ohrms/dockets/dockets/98n0182/nom007b.pdf'" tppabs="https://www.fda.gov/ohrms/dockets/dockets/98n0182/nom007b.pdf" class="external text external">"Diaminopyridine (3,4-)"</a> <span class="cs1-format">(PDF)</span>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">November 28,</span> 2015</span>.</cite>. Index page: <a href="javascript:if(confirm('https://www.fda.gov/ohrms/dockets/dockets/98n0182/98n0182.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/ohrms/dockets/dockets/98n0182/98n0182.htm'" tppabs="https://www.fda.gov/ohrms/dockets/dockets/98n0182/98n0182.htm" class="external text external">FDA Docket 98N-0812: Bulk Drug Substances to be Used in Pharmacy Compounding</a></span></li><li id="cite_note-Dinnendahl-9"> <span id="mw-reference-text-cite_note-Dinnendahl-9" class="mw-reference-text"><cite id="CITEREFDinnendahl,_VFricke,_U2015" class="citation book cs1">Dinnendahl, V; Fricke, U, eds. (2015). <i>Arzneistoff-Profile</i> (in German). <b>1</b> (28th ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN<span>&nbsp;</span><bdi>978-3-7741-9846-3</bdi>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFMahéNicolaïAllouchiBarrio2013" class="citation journal cs1">Mahé, Nathalie; Nicolaï, Béatrice; Allouchi, Hassan; Barrio, Maria; Do, Bernard; Céolin, René; Tamarit, Josep-Lluis; Rietveld, Ivo B. (2013). "Crystal Structure and Solid-State Properties of 3,4-Diaminopyridine Dihydrogen Phosphate and Their Comparison with Other Diaminopyridine Salts". <i>Cryst Growth Des</i>. <b>13</b> (2): 708–715. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fcg3014249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fcg3014249'" tppabs="https://doi.org/10.1021%2Fcg3014249" class="external text external">10.1021/cg3014249</a>.</cite></span></li><li id="cite_note-Klement-11"> <span id="mw-reference-text-cite_note-Klement-11" class="mw-reference-text"><cite id="CITEREFA._Klement2015" class="citation journal cs1">A. Klement (November 9, 2015). "Firdapse". <i>Österreichische Apothekerzeitung</i> (in German) (23/2015): 10f.</cite></span></li><li id="cite_note-NHS2015-12"> <span id="mw-reference-text-cite_note-NHS2015-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.engage.england.nhs.uk/consultation/clinical-commissioning-wave2/user_uploads/d04-x01-amifampridine-ev-review.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.engage.england.nhs.uk/consultation/clinical-commissioning-wave2/user_uploads/d04-x01-amifampridine-ev-review.pdf'" tppabs="https://www.engage.england.nhs.uk/consultation/clinical-commissioning-wave2/user_uploads/d04-x01-amifampridine-ev-review.pdf" class="external text external">"Evidence Review: Amifampridine phosphate for the treatment of Lambert–Easton Myasthenic Syndrome"</a> <span class="cs1-format">(PDF)</span>. NHS England. December 2015.</cite></span></li><li id="cite_note-NYT2015-13"> <span id="mw-reference-text-cite_note-NYT2015-13" class="mw-reference-text"><cite id="CITEREFTavernise2016" class="citation news cs1">Tavernise, Sabrina (February 17, 2016). <a href="javascript:if(confirm('https://www.nytimes.com/2016/02/18/health/fda-deals-setback-to-catalyst-in-race-for-drug-approval.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2016/02/18/health/fda-deals-setback-to-catalyst-in-race-for-drug-approval.html'" tppabs="https://www.nytimes.com/2016/02/18/health/fda-deals-setback-to-catalyst-in-race-for-drug-approval.html" class="external text external">"F.D.A. Deals Setback to Catalyst in Race for Drug Approval"</a>. <i>New York Times</i>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFDrummondTowse2014" class="citation journal cs1">Drummond, M; Towse, A (May 2014). <a href="javascript:if(confirm('https://doi.org/10.1007/s10198-014-0560-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007/s10198-014-0560-1'" tppabs="https://doi.org/10.1007/s10198-014-0560-1" class="external text external">"Orphan drugs policies: a suitable case for treatment"</a>. <i>The European Journal of Health Economics<span>&nbsp;</span>: HEPAC<span>&nbsp;</span>: Health Economics in Prevention and Care</i>. <b>15</b> (4): 335–40. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10198-014-0560-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10198-014-0560-1'" tppabs="https://doi.org/10.1007%2Fs10198-014-0560-1" class="external text external">10.1007/s10198-014-0560-1</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24435513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24435513'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24435513" class="external text external">24435513</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFLowe2013" class="citation news cs1">Lowe, Derek (October 21, 2013). <a href="javascript:if(confirm('http://blogs.sciencemag.org/pipeline/archives/2013/10/21/catalyst_pharmaceuticals_and_their_business_plan  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://blogs.sciencemag.org/pipeline/archives/2013/10/21/catalyst_pharmaceuticals_and_their_business_plan'" tppabs="http://blogs.sciencemag.org/pipeline/archives/2013/10/21/catalyst_pharmaceuticals_and_their_business_plan" class="external text external">"Catalyst Pharmaceuticals And Their Business Plan"</a>. <i>In the Pipeline</i>.</cite></span></li><li id="cite_note-BillHealth2016-16"> <span id="mw-reference-text-cite_note-BillHealth2016-16" class="mw-reference-text"><cite id="CITEREFDeak2016" class="citation news cs1">Deak, Dalia (February 22, 2016). <a href="javascript:if(confirm('http://blogs.harvard.edu/billofhealth/2016/02/22/jacobus-and-catalyst-approval/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://blogs.harvard.edu/billofhealth/2016/02/22/jacobus-and-catalyst-approval/'" tppabs="http://blogs.harvard.edu/billofhealth/2016/02/22/jacobus-and-catalyst-approval/" class="external text external">"Jacobus and Catalyst Continue to Race for Approval of LEMS Drug"</a>. <i>Bill of Health</i>.</cite></span></li><li id="cite_note-Stat2016-17"> <span id="mw-reference-text-cite_note-Stat2016-17" class="mw-reference-text"><cite id="CITEREFSilverman2016" class="citation news cs1">Silverman, Ed (April 5, 2016). <a href="javascript:if(confirm('https://www.statnews.com/pharmalot/2016/04/05/jacobus-pharmaceuticals-martin-shkreli/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.statnews.com/pharmalot/2016/04/05/jacobus-pharmaceuticals-martin-shkreli/'" tppabs="https://www.statnews.com/pharmalot/2016/04/05/jacobus-pharmaceuticals-martin-shkreli/" class="external text external">"A family-run drug maker tries to stay afloat in the Shkreli era"</a>. <i>STAT News</i>.</cite></span></li><li id="cite_note-DrugR&amp;D2015-18"> <span id="mw-reference-text-cite_note-DrugR&amp;D2015-18" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://yixiblog.wordpress.com/tag/jacobus-pharmaceuticals/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://yixiblog.wordpress.com/tag/jacobus-pharmaceuticals/'" tppabs="https://yixiblog.wordpress.com/tag/jacobus-pharmaceuticals/" class="external text external">"Jacobus Pharmaceuticals"</a>. <i>Drug R&amp;D Insight</i>. April 25, 2015.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html'" tppabs="https://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html" class="external text external">"BioMarin licenses North American rights to rare disease drug, invests $5M in Florida company"</a>. <i>www.bizjournals.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">December 17,</span> 2019</span>.</cite></span></li><li id="cite_note-EMAorphan-20"> <span id="mw-reference-text-cite_note-EMAorphan-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005405.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005405.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005405.pdf" class="external text external">"Public summary of opinion on orphan designation"</a> <span class="cs1-format">(PDF)</span>. EMA. June 14, 2010.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFChapelle2008" class="citation news cs1">Chapelle, François-Xavier (November 4, 2008). <a href="javascript:if(confirm('http://www.pemagazine.fr/MTQ3NQ/opi-ou-comment-construire-une-biopharma-en-moins-de-dix-ans  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pemagazine.fr/MTQ3NQ/opi-ou-comment-construire-une-biopharma-en-moins-de-dix-ans'" tppabs="http://www.pemagazine.fr/MTQ3NQ/opi-ou-comment-construire-une-biopharma-en-moins-de-dix-ans" class="external text external">"OPi ou comment construire une biopharma en moins de dix ans - Private Equity Magazine"</a>. <i>Private Equity Magazine</i> (in French).</cite></span></li><li id="cite_note-ZenasEMA2009-22"> <span id="mw-reference-text-cite_note-ZenasEMA2009-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001032/WC500069918.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001032/WC500069918.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001032/WC500069918.pdf" class="external text external">"Assessment report: Zenas"</a> <span class="cs1-format">(PDF)</span>. EMA CHMP committee. 2009.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.pharmaceutical-technology.com/news/news68256.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pharmaceutical-technology.com/news/news68256.html'" tppabs="http://www.pharmaceutical-technology.com/news/news68256.html" class="external text external">"Huxley Acquisition Lands Biomarin New LEMS Treatment"</a>. <i>Pharmaceutical Technology</i>. October 28, 2009.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFGoldberg2010" class="citation news cs1">Goldberg, Adrian (November 21, 2010). <a href="javascript:if(confirm('https://www.bbc.com/news/health-11798183  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bbc.com/news/health-11798183'" tppabs="https://www.bbc.com/news/health-11798183" class="external text external">"Drug firms accused of exploiting loophole for profit"</a>. <i>BBC News</i>.</cite></span></li><li id="cite_note-Nichol-25"> <span id="mw-reference-text-cite_note-Nichol-25" class="mw-reference-text"><cite id="CITEREFNichollHilton-JonesPalaceRichmond2010" class="citation journal cs1">Nicholl DJ, Hilton-Jones D, Palace J, Richmond S, Finlayson S, Winer J, Weir A, Maddison P, Fletcher N, Sussman J, Silver N, Nixon J, Kullmann D, Embleton N, Beeson D, Farrugia ME, Hill M, McDermott C, Llewelyn G, Leonard J, Morris M (2010). <a href="javascript:if(confirm('http://www.bmj.com/content/341/bmj.c6466.full  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bmj.com/content/341/bmj.c6466.full'" tppabs="http://www.bmj.com/content/341/bmj.c6466.full" class="external text external">"Open letter to prime minister David Cameron and health secretary Andrew Lansley"</a>. <i>BMJ</i>. <b>341</b>: c6466. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.c6466  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.c6466'" tppabs="https://doi.org/10.1136%2Fbmj.c6466" class="external text external">10.1136/bmj.c6466</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21081599  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21081599'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21081599" class="external text external">21081599</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFHawkesCohen2010" class="citation journal cs1">Hawkes N, Cohen D (2010). "What makes an orphan drug?". <i>BMJ</i>. <b>341</b>: c6459. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.c6459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.c6459'" tppabs="https://doi.org/10.1136%2Fbmj.c6459" class="external text external">10.1136/bmj.c6459</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21081607  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21081607'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21081607" class="external text external">21081607</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFVedelerAntoineGiomettoGraus2006" class="citation journal cs1">Vedeler, CA; Antoine, JC; Giometto, B; Graus, F; Grisold, W; Hart, IK; Honnorat, J; Sillevis Smitt, PA; Verschuuren, JJ; Voltz, R; Paraneoplastic Neurological Syndrome Euronetwork. (July 2006). "Management of paraneoplastic neurological syndromes: report of an EFNS Task Force". <i>European Journal of Neurology</i>. <b>13</b> (7): 682–90. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1468-1331.2006.01266.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1468-1331.2006.01266.x'" tppabs="https://doi.org/10.1111%2Fj.1468-1331.2006.01266.x" class="external text external">10.1111/j.1468-1331.2006.01266.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16834698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16834698'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16834698" class="external text external">16834698</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('http://www.who.int/medicines/publications/druginformation/innlists/RL58.pdf?ua=1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/druginformation/innlists/RL58.pdf?ua=1'" tppabs="http://www.who.int/medicines/publications/druginformation/innlists/RL58.pdf?ua=1" class="external text external">"International Nonproprietary Names for Pharmaceutical Substances (INN) Recommended INN: List 58"</a> <span class="cs1-format">(PDF)</span>. <i>WHO Drug Information</i>. <b>21</b> (3). 2007.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFWahl2012" class="citation news cs1">Wahl, Margaret (January 25, 2012). <a href="javascript:if(confirm('http://quest.mda.org/news/jacobus-begins-invitation-only-trial-34-dap-lems  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://quest.mda.org/news/jacobus-begins-invitation-only-trial-34-dap-lems'" tppabs="http://quest.mda.org/news/jacobus-begins-invitation-only-trial-34-dap-lems" class="external text external">"Jacobus Begins Invitation-Only Trial of 3,4-DAP in LEMS"</a>. <i>Muscular Dystrophy Association Quest Magazine Online</i>.</cite></span></li><li id="cite_note-SFBJ2012-30"> <span id="mw-reference-text-cite_note-SFBJ2012-30" class="mw-reference-text"><cite id="CITEREFLeuty2012" class="citation news cs1">Leuty, Ron (October 31, 2012). <a href="javascript:if(confirm('http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html'" tppabs="http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/10/biomarin-catalyst-firdapse-lems.html" class="external text external">"BioMarin licenses North American rights to rare disease drug, invests $5M in Florida company"</a>. <i>San Francisco Business Journal</i>.</cite></span></li><li id="cite_note-:0-31"> <span id="mw-reference-text-cite_note-:0-31" class="mw-reference-text"><cite id="CITEREFBaker2013" class="citation journal cs1">Baker DE (November 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287" class="external text external">"Breakthrough Drug Approval Process and Postmarketing ADR Reporting"</a>. <i>Hospital Pharmacy</i>. <b>48</b> (10): 796–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1310%2Fhpj4810-796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1310%2Fhpj4810-796'" tppabs="https://doi.org/10.1310%2Fhpj4810-796" class="external text external">10.1310/hpj4810-796</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859287" class="external text external">3859287</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24421428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24421428'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24421428" class="external text external">24421428</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=464814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=464814'" tppabs="http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=464814" class="external text external">"Orphan Drug Designations: amifampridine phosphate for congenital myasthenic syndromes"</a>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">January 14,</span> 2017</span>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=534916  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=534916'" tppabs="http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=534916" class="external text external">"Orphan Drug Designations: amifampridine phosphate for myasthenia gravis"</a>. <i>www.accessdata.fda.gov</i>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">January 14,</span> 2017</span>.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFRadke2014" class="citation news cs1">Radke, James (October 29, 2014). <a href="javascript:if(confirm('https://web.archive.org/web/20180613161250/http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180613161250/http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients'" tppabs="https://web.archive.org/web/20180613161250/http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients" class="external text external">"Catalyst Using the Expanded Access Program to Conduct Phase IV Study with LEMS Patients"</a>. <i>Rare Disease Report</i>. Archived from <a href="javascript:if(confirm('http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients'" tppabs="http://www.raredr.com/news/catalyst-expanded-access-program-lems-patients" class="external text external">the original</a> on June 13, 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">June 13,</span> 2018</span>.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20150726000108/https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150726000108/https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814'" tppabs="https://web.archive.org/web/20150726000108/https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814" class="external text external">"Orrphan designation congenital myasthenic syndromes"</a>. FDA. Archived from <a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814'" tppabs="https://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=464814" class="external text external">the original</a> on July 26, 2015.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFBurns2016" class="citation journal cs1">Burns, TM, et al.I (February 2016). "Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine". <i>Muscle &amp; Nerve</i>. <b>53</b> (2): 165–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmus.25009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmus.25009'" tppabs="https://doi.org/10.1002%2Fmus.25009" class="external text external">10.1002/mus.25009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26662952  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26662952'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26662952" class="external text external">26662952</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFMcEnany2017" class="citation journal cs1">McEnany, Patrick J. (2017). <a href="javascript:if(confirm('https://doi.org/10.1002/mus.25437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002/mus.25437'" tppabs="https://doi.org/10.1002/mus.25437" class="external text external">"A response to a recent editorial by concerned physicians on 3,4-diaminopyridine"</a>. <i>Muscle &amp; Nerve</i>. <b>55</b> (1): 138. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1002%2Fmus.25437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmus.25437'" tppabs="https://doi.org/10.1002%2Fmus.25437" class="external text external">10.1002/mus.25437</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1097-4598  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1097-4598'" tppabs="https://www.worldcat.org/issn/1097-4598" class="external text external">1097-4598</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27756108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27756108'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27756108" class="external text external">27756108</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFTavernise2015" class="citation news cs1">Tavernise, Sabrina (December 22, 2015). <a href="javascript:if(confirm('https://www.nytimes.com/2015/12/23/health/patients-fear-spike-in-price-of-old-drugs.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2015/12/23/health/patients-fear-spike-in-price-of-old-drugs.html'" tppabs="https://www.nytimes.com/2015/12/23/health/patients-fear-spike-in-price-of-old-drugs.html" class="external text external">"Patients Fear Spike in Price of Old Drugs"</a>. <i>New York Times</i>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFAdams2016" class="citation news cs1">Adams, Ben (April 26, 2016). <a href="javascript:if(confirm('http://www.fiercebiotech.com/biotech/catalyst-pharmaceuticals-hit-by-fda-extra-studies-request-for-firdapse  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fiercebiotech.com/biotech/catalyst-pharmaceuticals-hit-by-fda-extra-studies-request-for-firdapse'" tppabs="http://www.fiercebiotech.com/biotech/catalyst-pharmaceuticals-hit-by-fda-extra-studies-request-for-firdapse" class="external text external">"Catalyst Pharmaceuticals hit by FDA extra studies request for Firdapse"</a>. <i>FierceBiotech</i>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite class="citation news cs1">Adams, Ben (May 17, 2016). <a href="javascript:if(confirm('https://www.fiercebiotech.com/biotech/catalyst-to-ax-30-workforce-wake-fda-trial-demands  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fiercebiotech.com/biotech/catalyst-to-ax-30-workforce-wake-fda-trial-demands'" tppabs="https://www.fiercebiotech.com/biotech/catalyst-to-ax-30-workforce-wake-fda-trial-demands" class="external text external">"Catalyst to ax 30% of workforce in wake of FDA trial demands"</a>. <i>FierceBiotech</i>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite id="CITEREFLima2018" class="citation news cs1">Lima, Debora (March 29, 2018). <a href="javascript:if(confirm('https://www.bizjournals.com/southflorida/news/2018/03/29/catalyst-files-new-drug-application-with-fda.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bizjournals.com/southflorida/news/2018/03/29/catalyst-files-new-drug-application-with-fda.html'" tppabs="https://www.bizjournals.com/southflorida/news/2018/03/29/catalyst-files-new-drug-application-with-fda.html" class="external text external">"Catalyst Pharmaceuticals files new drug application with FDA"</a>. <i>South Florida Business Journa</i>.</cite></span></li><li id="cite_note-42"> <span id="mw-reference-text-cite_note-42" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/history/firdapse.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/history/firdapse.html'" tppabs="https://www.drugs.com/history/firdapse.html" class="external text external">"Firdapse (amifampridine phosphate) FDA Approval History"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 5,</span> 2019</span>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.nbcnews.com/politics/2020-election/bernie-sanders-asks-why-drug-once-free-now-costs-375-n966746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nbcnews.com/politics/2020-election/bernie-sanders-asks-why-drug-once-free-now-costs-375-n966746'" tppabs="https://www.nbcnews.com/politics/2020-election/bernie-sanders-asks-why-drug-once-free-now-costs-375-n966746" class="external text external">"Bernie Sanders asks why drug, once free, now costs $375K"</a>. <i>NBC News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">February 5,</span> 2019</span>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.nbcnews.com/health/health-news/family-outraged-over-life-changing-treatment-going-free-375-000-n968906  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nbcnews.com/health/health-news/family-outraged-over-life-changing-treatment-going-free-375-000-n968906'" tppabs="https://www.nbcnews.com/health/health-news/family-outraged-over-life-changing-treatment-going-free-375-000-n968906" class="external text external">"Family outraged over life-changing treatment going from free to $375,000 a year"</a>. <i>NBC News</i>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFDrash2019" class="citation news cs1">Drash, Wayne (May 8, 2019). <a href="javascript:if(confirm('https://edition.cnn.com/2019/05/08/health/fda-firdapse-expensive-drug-surprise-move/index.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://edition.cnn.com/2019/05/08/health/fda-firdapse-expensive-drug-surprise-move/index.html'" tppabs="https://edition.cnn.com/2019/05/08/health/fda-firdapse-expensive-drug-surprise-move/index.html" class="external text external">"FDA undercuts $375,000 drug in surprise move"</a>. <i>CNN Health</i><span class="reference-accessdate">. Retrieved <span class="nowrap">May 12,</span> 2019</span>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFSolariUitdehaagGiulianiPucci2002" class="citation journal cs1">Solari, A.; Uitdehaag, B.; Giuliani, G.; Pucci, E.; Taus, C. (2002). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571" class="external text external">"Aminopyridines for symptomatic treatment in multiple sclerosis"</a>. <i>The Cochrane Database of Systematic Reviews</i> (4): CD001330. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD001330  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD001330'" tppabs="https://doi.org/10.1002%2F14651858.CD001330" class="external text external">10.1002/14651858.CD001330</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1469-493X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1469-493X'" tppabs="https://www.worldcat.org/issn/1469-493X" class="external text external">1469-493X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047571" class="external text external">7047571</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12804404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12804404'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12804404" class="external text external">12804404</a>.</cite></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFSedehizadehKeoghMaddison2012" class="citation journal cs1">Sedehizadeh, S; Keogh, M; Maddison, P (2012). "The use of aminopyridines in neurological disorders". <i>Clinical Neuropharmacology</i>. <b>35</b> (4): 191–200. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FWNF.0b013e31825a68c5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FWNF.0b013e31825a68c5'" tppabs="https://doi.org/10.1097%2FWNF.0b013e31825a68c5" class="external text external">10.1097/WNF.0b013e31825a68c5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22805230  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22805230'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22805230" class="external text external">22805230</a>.</cite></span></li></ol></div></div>

<div role="navigation" class="navbox" aria-labelledby="Other_nervous_system_drugs_(N07X)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Other_nervous_system_drugs_(N07X)" style="font-size:114%;margin:0 4em">Other nervous system drugs (N07X)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Stroke</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Tirilazad</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ALS</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Riluzole.htm" tppabs="https://ptable.com/wiki/compounds/A/Riluzole" title="Riluzole">Riluzole</a></li>
<li>Xaliproden</li>
<li>Arimoclomol<sup><b>§</b></sup></li>
<li>Mecasermin rinfabate<sup><b>†</b></sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gamma-Hydroxybutyric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Gamma-Hydroxybutyric_acid" title="Gamma-Hydroxybutyric acid">Hydroxybutyric acid</a></li>
<li><a href="3,4-Diaminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Diaminopyridine" title="3,4-Diaminopyridine" class="mw-redirect">Amifampridine</a></li>
<li><a href="4-Aminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Aminopyridine" title="4-Aminopyridine">Fampridine</a></li>
<li>Inotersen</li>
<li>Tafamidis</li>
<li><i>hyperkinesis</i>
<ul><li>Deutetrabenazine</li>
<li><a href="Tetrabenazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a></li>
<li>Valbenazine</li></ul></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Ion_channel_modulators" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Ion_channel_modulators" style="font-size:114%;margin:0 4em">Ion channel modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Calcium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="VDCCs" scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VDCCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>L-type-selective:</b> <i>Dihydropyridines:</i> <a href="Amlodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amlodipine" title="Amlodipine">Amlodipine</a></li>
<li>Aranidipine</li>
<li>Azelnidipine</li>
<li>Barnidipine</li>
<li>Clevidipine</li>
<li><span class="new">Cronidipine</span></li>
<li>Darodipine</li>
<li><span class="new">Dexniguldipine</span></li>
<li><span class="new">Elgodipine</span></li>
<li><span class="new">Elnadipine</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><span class="new">Flordipine</span></li>
<li><span class="new">Furnidipine</span></li>
<li><span class="new">Iganidipine</span></li>
<li><a href="Isradipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Isradipine" title="Isradipine">Isradipine</a></li>
<li><a href="Lacidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lacidipine" title="Lacidipine">Lacidipine</a></li>
<li><span class="new">Lemildipine</span></li>
<li><a href="Lercanidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lercanidipine" title="Lercanidipine">Lercanidipine</a></li>
<li>Levamlodipine</li>
<li><span class="new">Levniguldipine</span></li>
<li>Manidipine</li>
<li>Mepirodipine</li>
<li><span class="new">Mesudipine</span></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Niguldipine</li>
<li>Niludipine</li>
<li>Nilvadipine</li>
<li><a href="Nimodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimodipine" title="Nimodipine">Nimodipine</a></li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li><a href="Nitrendipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrendipine" title="Nitrendipine">Nitrendipine</a></li>
<li><span class="new">Olradipine</span></li>
<li>Oxodipine</li>
<li><span class="new">Palonidipine</span></li>
<li>Pranidipine</li>
<li>Ryodipine (riodipine)</li>
<li><span class="new">Sagandipine</span></li>
<li><span class="new">Sornidipine</span></li>
<li><span class="new">Teludipine</span></li>
<li><span class="new">Tiamdipine</span></li>
<li><span class="new">Trombodipine</span></li>
<li><span class="new">Vatanidipine</span>; <i><a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">Diltiazem</a> derivatives:</i> Clentiazem</li>
<li><a href="Diltiazem.htm" tppabs="https://ptable.com/wiki/compounds/A/Diltiazem" title="Diltiazem">Diltiazem</a></li>
<li><span class="new">Iprotiazem</span></li>
<li><span class="new">Nictiazem</span></li>
<li><span class="new">Siratiazem</span>; <i>Phenylalkylamines:</i> Anipamil</li>
<li><span class="new">Dagapamil</span></li>
<li>Devapamil</li>
<li><span class="new">Dexverapamil</span></li>
<li><a href="Emopamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Emopamil" title="Emopamil">Emopamil</a></li>
<li><span class="new">Etripamil</span></li>
<li>Falipamil</li>
<li><a href="Gallopamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gallopamil" title="Gallopamil">Gallopamil</a></li>
<li><span class="new">Levemopamil</span></li>
<li><span class="new">Nexopamil</span></li>
<li>Norverapamil</li>
<li><span class="new">Ronipamil</span></li>
<li>Tiapamil</li>
<li><a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">Verapamil</a>; <i>Others:</i> AH-1058</li>
<li><span class="new">Brinazarone</span></li>
<li>Budiodarone</li>
<li>Celivarone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li>Dronedarone</li>
<li>Fantofarone</li>
<li><span class="new">SR-33805</span></li>
<li><a href="Tetrahydropalmatine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrahydropalmatine" title="Tetrahydropalmatine">Tetrahydropalmatine</a></li></ul>

<ul><li><b>N-type-selective:</b> ω-Conotoxins</li>
<li><span class="new">ω-Conotoxin GVIA</span></li>
<li>Caroverine</li>
<li><span class="new">Huwentoxin XVI</span></li>
<li>Leconotide (ω-conotoxin CVID)</li>
<li><span class="new">PD-173212</span></li>
<li>Ralfinamide</li>
<li>Safinamide</li>
<li><span class="new">Z160</span></li>
<li>Ziconotide (ω-conotoxin MVIIA)</li></ul>

<ul><li><b>P-type-selective:</b> <span class="new">ω-Agatoxin IVA</span></li>
<li><span class="new">ω-Agatoxin IVB</span></li></ul>

<ul><li><b>R-type-selective:</b> SNX-482</li></ul>

<ul><li><b>T-type-selective:</b> <span class="new">ABT-639</span></li>
<li><span class="new">ML-218</span></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><span class="new">NNC 55-0396</span></li>
<li><span class="new">ProTx I</span></li>
<li><span class="new">Z944</span></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>

<ul><li><b>Non-selective:</b> <span class="new">ω-Agatoxin TK</span></li>
<li><span class="new">ω-Conotoxin MVIIC</span></li>
<li>Benidipine</li>
<li><a href="Bepridil.htm" tppabs="https://ptable.com/wiki/compounds/A/Bepridil" title="Bepridil">Bepridil</a></li>
<li><a href="Cilnidipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cilnidipine" title="Cilnidipine">Cilnidipine</a></li>
<li><a href="Cinnarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cinnarizine" title="Cinnarizine">Cinnarizine</a></li>
<li>Dotarizine</li>
<li>Efonidipine</li>
<li><a href="Flunarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Flunarizine" title="Flunarizine">Flunarizine</a></li>
<li><a href="Lamotrigine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamotrigine" title="Lamotrigine">Lamotrigine</a></li>
<li><a href="Levetiracetam.htm" tppabs="https://ptable.com/wiki/compounds/A/Levetiracetam" title="Levetiracetam">Levetiracetam</a></li>
<li>Lomerizine</li>
<li><a href="Loperamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Loperamide" title="Loperamide">Loperamide</a></li>
<li><a href="Mibefradil.htm" tppabs="https://ptable.com/wiki/compounds/A/Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li><span class="new">NP078585</span></li>
<li>Ruthenium red</li>
<li>TROX-1</li></ul>

<ul><li><b>α<sub>2</sub>δ subunit-selective (gabapentinoids):</b> 4-Methylpregabalin</li>
<li>Arbaclofen</li>
<li>Arbaclofen placarbil</li>
<li>Atagabalin</li>
<li><a href="Baclofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Baclofen" title="Baclofen">Baclofen</a></li>
<li><a href="Gabapentin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gabapentin" title="Gabapentin">Gabapentin</a></li>
<li>Gabapentin enacarbil</li>
<li>Imagabalin</li>
<li>Mirogabalin</li>
<li><span class="new">PD-200,347</span></li>
<li>PD-217,014</li>
<li><span class="new">PD-299,685</span></li>
<li>Phenibut</li>
<li><a href="Pregabalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregabalin" title="Pregabalin">Pregabalin</a></li></ul>

<ul><li><b>Others/unsorted:</b> Bencyclane</li>
<li>Berbamine</li>
<li><a href="Bevantolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bevantolol" title="Bevantolol">Bevantolol</a></li>
<li>Canadine</li>
<li>Carboxyamidotriazole</li>
<li>Cycleanine</li>
<li>Dauricine</li>
<li>Dimeditiapramine</li>
<li>Diproteverine</li>
<li>Enpiperate</li>
<li>Eperisone</li>
<li><span class="new">Elpetrigine</span></li>
<li>Ethadione</li>
<li>Ethanol (alcohol)</li>
<li><a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li>Fasudil</li>
<li>Fendiline</li>
<li>Fostedil</li>
<li>Imepitoin</li>
<li><a href="JTV-519.htm" tppabs="https://ptable.com/wiki/compounds/A/JTV-519" title="JTV-519">JTV-519</a></li>
<li><a href="Lidoflazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidoflazine" title="Lidoflazine">Lidoflazine</a></li>
<li><a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">Magnesium</a></li>
<li>Manoalide</li>
<li><a href="Mesuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesuximide" title="Mesuximide">Mesuximide</a></li>
<li>Monatepil</li>
<li><a href="Naftopidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Naftopidil" title="Naftopidil">Naftopidil</a></li>
<li><a href="Ochratoxin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Ochratoxin_A" title="Ochratoxin A">Ochratoxin A</a></li>
<li>Osthol</li>
<li>Otilonium bromide</li>
<li><a href="Paramethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Paramethadione" title="Paramethadione">Paramethadione</a></li>
<li><a href="Phensuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phensuximide" title="Phensuximide">Phensuximide</a></li>
<li>Pinaverium bromide</li>
<li><a href="Prenylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prenylamine" title="Prenylamine">Prenylamine</a></li>
<li>Rhynchophylline</li>
<li>Sesamodil</li>
<li>Silperisone</li>
<li><span class="new">Sipatrigine</span></li>
<li>Terodiline</li>
<li><a href="Tetrandrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrandrine" title="Tetrandrine">Tetrandrine</a></li>
<li>Tolperisone</li>
<li><a href="Trimethadione.htm" tppabs="https://ptable.com/wiki/compounds/A/Trimethadione" title="Trimethadione">Trimethadione</a></li>
<li>Valperinol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>L-type-selective:</b> Bay K8644</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Potassium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VGKCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="3,4-Diaminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/3%2C4-Diaminopyridine" title="3,4-Diaminopyridine" class="mw-redirect">3,4-Diaminopyridine (amifampridine)</a></li>
<li><a href="4-Aminopyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Aminopyridine" title="4-Aminopyridine">4-Aminopyridine (fampridine/dalfampridine)</a></li>
<li><span class="new">Adekalant</span></li>
<li>Almokalant</li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>Azimilide</li>
<li><a href="Bretylium.htm" tppabs="https://ptable.com/wiki/compounds/A/Bretylium" title="Bretylium">Bretylium</a></li>
<li>Bunaftine</li>
<li>Charybdotoxin</li>
<li><span class="new">Clamikalant</span></li>
<li>Conotoxins</li>
<li><span class="new">Dalazatide</span></li>
<li>Dendrotoxin</li>
<li><a href="Dofetilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Dofetilide" title="Dofetilide">Dofetilide</a></li>
<li>Dronedarone</li>
<li>E-4031</li>
<li>Hanatoxin</li>
<li>HgeTx1</li>
<li>HsTx1</li>
<li><a href="Ibutilide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibutilide" title="Ibutilide">Ibutilide</a></li>
<li><span class="new">Inakalant</span></li>
<li>Kaliotoxin</li>
<li>Linopirdine</li>
<li>Lolitrem B</li>
<li>Maurotoxin</li>
<li>Nifekalant</li>
<li><span class="new">Notoxin</span></li>
<li><a href="Paxilline.htm" tppabs="https://ptable.com/wiki/compounds/A/Paxilline" title="Paxilline">Paxilline</a></li>
<li><span class="new">Pinokalant</span></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><span class="new">ShK-186</span></li>
<li><a href="Sotalol.htm" tppabs="https://ptable.com/wiki/compounds/A/Sotalol" title="Sotalol">Sotalol</a></li>
<li>Tedisamil</li>
<li><span class="new">Terikalant</span></li>
<li><a href="Tetraethylammonium.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetraethylammonium" title="Tetraethylammonium">Tetraethylammonium</a></li>
<li>Vernakalant</li></ul>

<ul><li><b>hERG (KCNH2, K<sub>v</sub>11.1)-specific:</b> <a href="Ajmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li>AmmTX3</li>
<li><a href="Astemizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Astemizole" title="Astemizole">Astemizole</a></li>
<li>Azaspiracid</li>
<li>AZD1305</li>
<li>Azimilide</li>
<li>Bedaquiline</li>
<li>BeKm-1</li>
<li>BmTx3</li>
<li>BRL-32872</li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Cisapride.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisapride" title="Cisapride">Cisapride</a></li>
<li><a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">Clarithromycin</a></li>
<li><a href="Darifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Darifenacin" title="Darifenacin">Darifenacin</a></li>
<li><a href="Dextropropoxyphene.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextropropoxyphene" title="Dextropropoxyphene">Dextropropoxyphene</a></li>
<li>Diallyl trisulfide</li>
<li><a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">Domperidone</a></li>
<li>E-4031</li>
<li>Ergtoxins</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Gigactonine</li>
<li><a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">Haloperidol</a></li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Norpropoxyphene</li>
<li><a href="Orphenadrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="Pimozide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimozide" title="Pimozide">Pimozide</a></li>
<li>PNU-282,987</li>
<li><a href="Promethazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Promethazine" title="Promethazine">Promethazine</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li><a href="Ranolazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranolazine" title="Ranolazine">Ranolazine</a></li>
<li><a href="Roxithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li><a href="Sertindole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sertindole" title="Sertindole">Sertindole</a></li>
<li><a href="Solifenacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Solifenacin" title="Solifenacin">Solifenacin</a></li>
<li>Tamulotoxin</li>
<li>Terodiline</li>
<li><a href="Terfenadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Terfenadine" title="Terfenadine">Terfenadine</a></li>
<li><a href="Thioridazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thioridazine" title="Thioridazine">Thioridazine</a></li>
<li><a href="Tolterodine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolterodine" title="Tolterodine">Tolterodine</a></li>
<li><a href="Vanoxerine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vanoxerine" title="Vanoxerine">Vanoxerine</a></li>
<li>Vernakalant</li></ul>

<ul><li><b>KCNQ (K<sub>v</sub>7)-specific:</b> Linopirdine</li>
<li><span class="new">XE-991</span></li>
<li>Spooky toxin (SsTx)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>KCNQ (K<sub>v</sub>7)-specific:</b> Flupirtine</li>
<li>Retigabine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>IRKs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>K<sub>ATP</sub></abbr>-specific:</b> <a href="Acetohexamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetohexamide" title="Acetohexamide">Acetohexamide</a></li>
<li><a href="Carbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbutamide" title="Carbutamide">Carbutamide</a></li>
<li><a href="Chlorpropamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a></li>
<li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide (glyburide)</a></li>
<li>Glibornuride</li>
<li>Glicaramide</li>
<li><a href="Gliclazide.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliclazide" title="Gliclazide">Gliclazide</a></li>
<li><a href="Glimepiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Glimepiride" title="Glimepiride">Glimepiride</a></li>
<li><a href="Glipizide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glipizide" title="Glipizide">Glipizide</a></li>
<li><a href="Gliquidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliquidone" title="Gliquidone">Gliquidone</a></li>
<li><a href="Glisoxepide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glisoxepide" title="Glisoxepide">Glisoxepide</a></li>
<li>Glyclopyramide</li>
<li><span class="new">Glycyclamide</span></li>
<li>Metahexamide</li>
<li><a href="Mitiglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitiglinide" title="Mitiglinide">Mitiglinide</a></li>
<li><a href="Nateglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nateglinide" title="Nateglinide">Nateglinide</a></li>
<li><a href="Repaglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Repaglinide" title="Repaglinide">Repaglinide</a></li>
<li><a href="Tolazamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolazamide" title="Tolazamide">Tolazamide</a></li>
<li><a href="Tolbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolbutamide" title="Tolbutamide">Tolbutamide</a></li></ul>

<ul><li><b><abbr>GIRK</abbr>-specific:</b> <a href="Barium.htm" tppabs="https://ptable.com/wiki/compounds/A/Barium" title="Barium">Barium</a></li>
<li>Caramiphen</li>
<li>Cloperastine</li>
<li><a href="Clozapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clozapine" title="Clozapine">Clozapine</a></li>
<li><a href="Dextromethorphan.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a></li>
<li><a href="Ethosuximide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethosuximide" title="Ethosuximide">Ethosuximide</a></li>
<li>Ifenprodil</li>
<li>Tertiapin</li>
<li>Tipepidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b><abbr>K<sub>ATP</sub></abbr>-specific:</b> <span class="new">Aprikalim</span></li>
<li>Bimakalim</li>
<li>Cromakalim</li>
<li><a href="Diazoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazoxide" title="Diazoxide">Diazoxide</a></li>
<li><span class="new">Emakalim</span></li>
<li>Levcromakalim</li>
<li><span class="new">Mazokalim</span></li>
<li><a href="Minoxidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Minoxidil" title="Minoxidil">Minoxidil</a></li>
<li><span class="new">Naminidil</span></li>
<li>Nicorandil</li>
<li><a href="Pinacidil.htm" tppabs="https://ptable.com/wiki/compounds/A/Pinacidil" title="Pinacidil">Pinacidil</a></li>
<li><span class="new">Rilmakalim</span></li>
<li><span class="new">Sarakalim</span></li></ul>

<ul><li><b><abbr>GIRK</abbr>-specific:</b> <span class="new">ML-297 (VU0456810)</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>K<sub>Ca</sub></abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>BK<sub>Ca</sub>-specific:</b> Ethanol (alcohol)</li>
<li>GAL-021</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><b>BK<sub>Ca</sub>-specific:</b> <a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><a href="Nimesulide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nimesulide" title="Nimesulide">Nimesulide</a></li>
<li><a href="Rottlerin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rottlerin" title="Rottlerin">Rottlerin (mallotoxin)</a></li>
<li><a href="Tolfenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>K2Ps</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="12-O-Tetradecanoylphorbol-13-acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/12-O-Tetradecanoylphorbol-13-acetate" title="12-O-Tetradecanoylphorbol-13-acetate">12-O-Tetradecanoylphorbol-13-acetate</a></li>
<li><a href="Arachidonic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li>Norfluoxetine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Riluzole.htm" tppabs="https://ptable.com/wiki/compounds/A/Riluzole" title="Riluzole">Riluzole</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Sodium</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>VGSCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Antianginals:</i> <a href="Ranolazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranolazine" title="Ranolazine">Ranolazine</a></li></ul>

<ul><li><i>Antiarrhythmics (class I):</i> <a href="Ajmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Ajmaline" title="Ajmaline">Ajmaline</a></li>
<li><a href="Aprindine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aprindine" title="Aprindine">Aprindine</a></li>
<li><a href="Disopyramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Disopyramide" title="Disopyramide">Disopyramide</a></li>
<li>Dronedarone</li>
<li><a href="Encainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Encainide" title="Encainide">Encainide</a></li>
<li><a href="Flecainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flecainide" title="Flecainide">Flecainide</a></li>
<li><a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li>Lorajmine</li>
<li>Lorcainide</li>
<li><a href="Mexiletine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mexiletine" title="Mexiletine">Mexiletine</a></li>
<li><a href="Moracizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Moracizine" title="Moracizine">Moricizine</a></li>
<li>Pilsicainide</li>
<li>Prajmaline</li>
<li><a href="Procainamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Procainamide" title="Procainamide">Procainamide</a></li>
<li><a href="Propafenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Propafenone" title="Propafenone">Propafenone</a></li>
<li><a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a></li>
<li>Sparteine</li>
<li><a href="Tocainide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tocainide" title="Tocainide">Tocainide</a></li></ul>

<ul><li><i>Anticonvulsants:</i> <span class="new">Acetylpheneturide</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li>Cenobamate</li>
<li>Chlorphenacemide</li>
<li><span class="new">Elpetrigine</span></li>
<li>Eslicarbazepine acetate</li>
<li><a href="Ethotoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethotoin" title="Ethotoin">Ethotoin</a></li>
<li><a href="Fosphenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosphenytoin" title="Fosphenytoin">Fosphenytoin</a></li>
<li>Lacosamide</li>
<li>Licarbazepine</li>
<li><a href="Mephenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mephenytoin" title="Mephenytoin">Mephenytoin</a></li>
<li><a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a></li>
<li>Oxitriptyline</li>
<li><a href="Phenacemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenacemide" title="Phenacemide">Phenacemide</a></li>
<li>Pheneturide</li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Rufinamide</li>
<li><span class="new">Sipatrigine</span></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li><a href="Sodium_valproate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_valproate" title="Sodium valproate" class="mw-redirect">Sodium valproate</a></li>
<li>Valnoctamide</li>
<li>Valproate pivoxil</li>
<li><a href="Valproate_semisodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproate_semisodium" title="Valproate semisodium" class="mw-redirect">Valproate semisodium</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><a href="Valpromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Valpromide" title="Valpromide">Valpromide</a></li>
<li><a href="Zonisamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Zonisamide" title="Zonisamide">Zonisamide</a></li></ul>

<ul><li><i>Local anesthetics:</i> <i>p</i>FBT</li>
<li>Amylocaine</li>
<li>Articaine</li>
<li><a href="Benzocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzocaine" title="Benzocaine">Benzocaine</a></li>
<li><a href="Bupivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bupivacaine" title="Bupivacaine">Bupivacaine</a> (<a href="Levobupivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levobupivacaine" title="Levobupivacaine">Levobupivacaine</a>, <a href="Ropivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ropivacaine" title="Ropivacaine">Ropivacaine</a>)</li>
<li><a href="Butacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Butacaine" title="Butacaine">Butacaine</a></li>
<li><a href="Butamben.htm" tppabs="https://ptable.com/wiki/compounds/A/Butamben" title="Butamben">Butamben</a></li>
<li><a href="Chloroprocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroprocaine" title="Chloroprocaine">Chloroprocaine</a></li>
<li>Cinchocaine</li>
<li><a href="Cocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cocaine" title="Cocaine">Cocaine</a></li>
<li>Cyclomethycaine</li>
<li>Dimethocaine</li>
<li><a href="Diphenhydramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li>Etidocaine</li>
<li><a href="Hexylcaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hexylcaine" title="Hexylcaine">Hexylcaine</a></li>
<li>Iontocaine</li>
<li><a href="Lidocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lidocaine" title="Lidocaine">Lidocaine</a></li>
<li><a href="Mepivacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mepivacaine" title="Mepivacaine">Mepivacaine</a></li>
<li>Meprylcaine</li>
<li>Metabutoxycaine</li>
<li>Orthocaine</li>
<li>Piperocaine</li>
<li><a href="Prilocaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prilocaine" title="Prilocaine">Prilocaine</a></li>
<li><a href="Procaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procaine" title="Procaine">Procaine</a></li>
<li>Propoxycaine</li>
<li><a href="Proxymetacaine.htm" tppabs="https://ptable.com/wiki/compounds/A/Proxymetacaine" title="Proxymetacaine">Proxymetacaine</a></li>
<li>Risocaine</li>
<li>Tetracaine</li>
<li>Trimecaine</li></ul>

<ul><li><i>Analgesics:</i> <span class="new">AZD-3161</span></li>
<li>DSP-2230</li>
<li>Funapide</li>
<li><span class="new">GDC-0276</span></li>
<li><span class="new">NKTR-171</span></li>
<li><span class="new">PF-04531083</span></li>
<li>PF-05089771</li>
<li>Ralfinamide</li>
<li>Raxatrigine</li>
<li><span class="new">RG7893 (GDC-0287)</span></li></ul>

<ul><li><i>Toxins:</i> Conotoxins</li>
<li>Neosaxitoxin</li>
<li>Saxitoxin</li>
<li><a href="Tetrodotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetrodotoxin" title="Tetrodotoxin">Tetrodotoxin</a></li>
<li>Zetekitoxin AB</li></ul>

<ul><li><i>Others:</i> <a href="Buprenorphine.htm" tppabs="https://ptable.com/wiki/compounds/A/Buprenorphine" title="Buprenorphine">Buprenorphine</a></li>
<li>Evenamide</li>
<li><a href="Menthol.htm" tppabs="https://ptable.com/wiki/compounds/A/Menthol" title="Menthol">Menthol</a> (mint)</li>
<li>Safinamide</li>
<li>Tricyclic antidepressants</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aconitine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aconitine" title="Aconitine">Aconitine</a></li>
<li>Atracotoxins (ω-Atracotoxin, Robustoxin, <span class="new">Versutoxin</span>)</li>
<li>Batrachotoxin</li>
<li>Ciguatoxins</li>
<li>Grayanotoxins</li>
<li>Poneratoxin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>ENaC</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amiloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiloride" title="Amiloride">Amiloride</a></li>
<li>Benzamil</li>
<li><a href="Triamterene.htm" tppabs="https://ptable.com/wiki/compounds/A/Triamterene" title="Triamterene">Triamterene</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">Solnatide</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>ASICs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">A-317567</span></li>
<li><a href="Amiloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiloride" title="Amiloride">Amiloride</a></li>
<li><a href="Aspirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aspirin" title="Aspirin">Aspirin</a></li>
<li><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a></li>
<li><span class="new">PcTX1</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Chloride</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>CaCCs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Crofelemer</li>
<li>DIDS</li>
<li>Ethacrynic acid</li>
<li><a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Fluoxetine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxetine" title="Fluoxetine">Fluoxetine</a></li>
<li><a href="Furosemide.htm" tppabs="https://ptable.com/wiki/compounds/A/Furosemide" title="Furosemide">Furosemide</a></li>
<li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Mefloquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefloquine" title="Mefloquine">Mefloquine</a></li>
<li><a href="Mibefradil.htm" tppabs="https://ptable.com/wiki/compounds/A/Mibefradil" title="Mibefradil">Mibefradil</a></li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Carbachol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbachol" title="Carbachol">Carbachol</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>CFTR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide</a></li>
<li><a href="Lonidamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li><a href="Piretanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Piretanide" title="Piretanide">Piretanide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Activators</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">1,7-Phenanthroline</span></li>
<li><span class="new">1,10-Phenanthroline</span></li>
<li><span class="new">4,7-Phenanthroline</span></li>
<li><span class="new">7,8-Benzoquinoline</span></li>
<li>Ivacaftor</li>
<li><a href="Phenanthridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenanthridine" title="Phenanthridine">Phenanthridine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Unsorted</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;">Blockers</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Bumetanide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bumetanide" title="Bumetanide">Bumetanide</a></li>
<li><a href="Flufenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flufenamic_acid" title="Flufenamic acid">Flufenamic acid</a></li>
<li><a href="Meclofenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Meclofenamic_acid" title="Meclofenamic acid">Meclofenamic acid</a></li>
<li><a href="Mefenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mefenamic_acid" title="Mefenamic acid">Mefenamic acid</a></li>
<li>Mepacrine</li>
<li><a href="Niflumic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Niflumic_acid" title="Niflumic acid">Niflumic acid</a></li>
<li><span class="new">Talniflumate</span></li>
<li><a href="Tolfenamic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolfenamic_acid" title="Tolfenamic acid">Tolfenamic acid</a></li>
<li><a href="Trifluoperazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluoperazine" title="Trifluoperazine">Trifluoperazine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>TRPs</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:5em;;text-align:center;"><abbr>LGICs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>See here instead.</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div><i><b>See also:</b> Receptor/signaling modulators • Transient receptor potential channel modulators</i></div></td></tr></tbody></table></div>



<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2017-01-14" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=3%2C4-Diaminopyridine&oldid=759946501  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=3%2C4-Diaminopyridine&oldid=759946501'" tppabs="https://en.wikipedia.org/wiki/?title=3%2C4-Diaminopyridine&oldid=759946501">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>



</body></html>